三拗片联合常规西药治疗老年慢性支气管炎急性发作临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R562.21

基金项目:


Clinical Study on San'ao Tablets Combined with Routine Western Medicine for Acute Exacerbation of Chronic Bronchitis in Senile Patients
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察三拗片联合常规西药治疗老年慢性支气管炎急性发作的临床疗效。方法:选取老年慢 性支气管炎急性发作患者94 例,按随机数字表法分为观察组和对照组各47 例。对照组给予常规西药治疗,观 察组在对照组基础上联合三拗片治疗。评价2 组临床疗效,比较2 组治疗前后中医证候评分、肺功能指标和炎 性因子水平,观察不良反应发生情况。结果:观察组总有效率为97.87%,高于对照组82.98%(P<0.05)。治 疗后,2 组咳嗽、畏寒、咳痰评分及总分较治疗前降低(P<0.05),且观察组咳嗽、畏寒、咳痰评分及总分低 于对照组(P<0.05)。治疗后,2 组用力肺活量(FVC)、第1 秒用力呼气容积(FEV1)、FEV1/FVC 较治疗 前升高(P<0.05),且观察组FEV1、FVC、FEV1/FVC 高于对照组(P<0.05)。治疗后,2 组肿瘤坏死因 子-α (TNF-α)、白细胞介素-4 (IL-4)、白细胞介素-6 (IL-6) 水平较治疗前降低(P<0.05),且观察组 TNF-α、IL-4、IL-6 水平低于对照组(P<0.05)。观察组不良反应发生率为4.26%,低于对照组19.15%(P< 0.05)。结论:三拗片联合常规西药治疗老年慢性支气管炎急性发作疗效较好,能减轻患者的临床症状,有效 改善肺功能,降低血清炎性因子水平,安全性较好。

    Abstract:

    Abstract: Objective: To observe the clinical effect of San'ao Tablets combined with routine western medicine for acute exacerbation of chronic bronchitis in senile patients. Methods: A total of 94 cases of senile patients with acute exacerbation of chronic bronchitis were selected and divided into the observation group and the control group according to the random number table method,with 47 cases in each group. The control group was treated with routine western medicine,and the observation group was additionally treated with San'ao Tablets based on the treatment of the control group. The clinical effects in the two groups were evaluated. Before and after treatment, the traditional Chinese medicine syndrome scores, the lung function indexes,and the levels of inflammatory factors were compared between the two groups. The occurrence of adverse reactions was observed. Results: The total effective rate was 97.87% in the observation group,higher than that of 82.98% in the control group (P<0.05). After treatment,the scores of coughing, fear of cold, and expectoration as well as and the total scores in the two groups were decreased when compared with those before treatment (P<0.05),and the above scores in the observation group were lower than those in the control group (P<0.05). After treatment, forced vital capacity (FVC), forced expiratory volume at the first second (FEV1),and FEV1/FVC in the two groups were increased when compared with those before treatment (P<0.05), and the levels of FEV1, FVC, and FEV1/FVC in the observation group were higher than those in the control group (P<0.05). After treatment, the levels of tumor necrosis factor- α (TNF- α),interleukin- 4 (IL- 4),and interleukin- 6 (IL- 6) in the two groups were decreased when compared with those before treatment (P<0.05),and the levels of TNF- α,IL- 4,and IL- 6 in the observation group were lower than those in the control group (P<0.05). The incidence of adverse reactions was 4.26% in the observation group,lower than that of 19.15% in the control group (P< 0.05). Conclusion: San'ao Tablets combined with routine western medicine has a good curative effect in the treatment of acute exacerbation of chronic bronchitis in senile patients,which can reduce their clinical symptoms, effectively improve lung function, and reduce the levels of serum inflammatory factors with good safety.

    参考文献
    相似文献
    引证文献
引用本文

陈丽萍,安守信.三拗片联合常规西药治疗老年慢性支气管炎急性发作临床研究[J].新中医,2023,55(13):67-70

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-07-14
  • 出版日期:
文章二维码